MS: Could Roche’s bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS? Post date 15 April 2026 ← Medical news in brief: Long covid’s £8bn “shadow,” 38 measles deaths in Bangladesh, senior doctors’ ballot, and other stories → Effectiveness of interventions to increase vaccine uptake